To evaluate Pendulum GLP-1 Probiotic, separate its label from its cravings claims and your intended outcome. The manufacturer’s November 9 product page says the supplement is not intended for weight loss. The survey discussion explains why a reported change in cravings does not establish a weight-loss result or a benefit during GLP-1 medication treatment.
This review covers the US GLP-1 Probiotic product, not Pendulum Glucose Control, Metabolic Daily or a professional variant. Product-page and label observations are dated November 9, 2026; the science page and study directory were checked again November 11. Culture & Context has a commercial connection with CoreAge Rx, which receives sponsored first placement. We have not taken this product, tested a bottle or independently reviewed it as clinicians. Earlier access dates remain in the source register.
Two named strain codes and one open question
The manufacturer-hosted Supplement Facts image lists Clostridium butyricum WB-STR-0006 and Akkermansia muciniphila WB-STR-0001. It also lists Bifidobacterium infantis without an accompanying strain identifier in that image. The full image is a better record of those details than an abbreviated product description or an image's alternative text.
That missing third identifier matters when somebody tries to connect the product with research on a specific Bifidobacterium strain. The name B. infantis by itself does not establish that it is the organism used in an unrelated study. Our strain-name guide explains the difference between a species and the more specific code that follows it.
The reviewed panel shows one capsule as its serving size, 30 servings per container, a total blend of 500 million AFU and 211 mg of chicory inulin. Other listed ingredients are microcrystalline cellulose, hypromellose and silica. Those are label facts, not instructions from us about an individual's use. The total does not disclose how many AFU belong to each organism.
Keep AFU attached to the amount
The letters AFU should travel with the 500 million figure whenever the amount is copied into a comparison. It is not a 500-million-CFU declaration. Different enumeration methods can describe different aspects of a preparation, and this review does not calculate an equivalence between them or independently verify the laboratory result.
For a useful comparison, ask which method was used, when the amount is guaranteed and what storage conditions apply. The CFU, AFU and milligram guide explains why a single numerical ranking would hide those questions. Our label record also does not establish the blend's separate amount for each strain or its precise remaining count in a delivered bottle.
The cravings headline describes a consumer survey
The storefront attributes its prominent 91% reduced-cravings figure to a consumer study of 274 people over six weeks. That tells a reader what the company says participants reported. The reviewed presentation does not establish a randomized, blinded, placebo-controlled comparison for that percentage. A before-and-after report can reflect expectations and other changes alongside the product.
The site's GLP-1 mechanism statements also carry a preclinical qualification. Cell or animal findings may motivate human research, but they do not demonstrate a weight-loss result in people using the retail capsule. The manufacturer explicitly says the supplement does not contain GLP-1 and is not a GLP-1 agonist drug. These distinctions belong beside the headline, not several clicks away.
On November 11, 2026, Pendulum’s research directory still described a two-phase healthy-adult study with an estimated 2025 completion date. A sponsor’s listing does not verify current recruitment or provide a published result. Its separate Glucose Control entry concerns another product; those outcomes cannot simply be assigned to the three-organism GLP-1 Probiotic reviewed here.
What the public offer showed
The November 9 product data listed $64 billed monthly, $173 every 90 days for a three-month supply, and an $89 one-time purchase. These are recorded options, not a verified selection or checkout total. We could not reconfirm the offers on November 11; check the full charge and renewal terms before ordering.
The three-month offer represents a larger charge at each billing event even though dividing the total produces a smaller monthly equivalent. A shopper should compare commitment, delivery timing, shipping, tax and the terms that govern future orders. We verified public choices and price displays, not payment, reimbursement, fulfillment or cancellation.
If you want to compare the commercial records, our CoreAge review keeps its starting bottle price and unresolved label details separate. A cheaper-looking offer does not resolve a strain question; a more complete panel does not establish that a product belongs in your care plan.
Refrigerator advice does not settle suitability
The Pendulum label says to refrigerate for optimal quality. Ask the seller about the actual shipping conditions and any temperature excursion instead of guessing that a warm package is either ruined or unquestionably fine. A photo of the lot and expiry information can make the inquiry more useful. See the delivery and storage guide.
The manufacturer's FAQ says this product has not been studied in people who are pregnant, planning pregnancy or breastfeeding. It also describes possible digestive symptoms when starting a probiotic. Neither statement provides an individual safety assessment. In particular, worsening or persistent symptoms while taking a prescription deserve attention from the care team, not an assumption that the supplement needs more time.
Pendulum's clearest documented features here are its public panel, two explicit strain codes, AFU blend declaration and visible billing options. The unanswered questions concern the third identifier, exact evidence for a person's goal and the interpretation of the consumer survey. Our comparison preserves those differences rather than assigning a clinical winner.
Sources & reading limits
Access dates appear with each source. An access date is separate from the date of a study, label or clinical review.
- Pendulum — GLP-1 Probiotic
Manufacturer product page. Accessed 2026-09-26. Rendered public offers and consumer-survey qualification checked. Purchase, fulfillment, cancellation and reimbursement were not tested. Survey and preclinical statements are not established clinical outcomes for medication users.
- Pendulum — GLP-1 Probiotic facts image
Manufacturer label image. Accessed 2026-09-26. Visually inspected: 500 million AFU blend, two named strain codes, B. infantis without code, 211 mg chicory inulin, 30 one-capsule servings. Does not establish a per-strain amount or CFU equivalence.
- Pendulum — GLP-1 science page
Manufacturer research summary. Accessed 2026-09-26. Preclinical qualification and 274-person consumer-study description. Not independently controlled evidence of a retail-product weight-loss or prescription-tolerability outcome.
- Pendulum — clinical-trials directory
Sponsor research directory. Accessed 2026-09-26. The two-phase healthy-adult entry still lists estimated 2025 completion and active/fully enrolled wording. Current status and completed findings were not independently established. Other formulas are distinct.
- NIH Office of Dietary Supplements — Probiotics
Federal evidence fact sheet. Accessed 2026-09-27. Strain-specific evidence, label counts, shelf-life and safety context. General review; not endorsement or testing of the retail products.
- NCCIH — Probiotics: Usefulness and Safety
Federal health resource. Accessed 2026-09-27. Evidence limitations and greater potential risk in severe illness or compromised immunity. Access date does not update the underlying studies.
